For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230504:nRSD4740Ya&default-theme=true
RNS Number : 4740Y Integrated Diagnostics Holdings PLC 04 May 2023
Integrated Diagnostics Holdings PLC
4 May 2023
Integrated Diagnostic Holdings plc (the "Company")
Annual Financial Report & Notice of AGM
4 May 2023
Following the Company's announcement of Final Results issued on 6 April 2023,
Integrated Diagnostics Holdings plc (the 'Company') has today posted its
Annual Accounts for the year ended 31 December 2022 and Annual General Meeting
("AGM") Circular to shareholders.
In accordance with Disclosure Guidance and Transparency Rules 6.3.5 the Annual
Accounts are available on the Company's website ( www.idhcorp.com
(http://www.idhcorp.com/) ). Furthermore, in accordance with Listing Rule
14.3.6, each above mentioned document are available for inspection via the
National Storage Mechanism
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
The Company will be holding its Annual General Meeting on Tuesday, 30 May 2023
at 3pm (BST) / 4pm (EET) at the offices of Actis, 2 More London Riverside,
London SE1 2JT.
If you are unable to attend the AGM but would like to vote on the Resolutions,
kindly request to submit your proxy vote online at www.signalshares.com
(http://www.signalshares.com) or in accordance with the instructions set out
in note 2 of the Explanatory Notes to the Notice of the AGM which can be found
on the Company's website.
Shareholders wishing to access the dial-in facility or submit questions are
asked to email nancy.fahmy@idhcorp.com (mailto:nancy.fahmy@idhcorp.com)
by close of business on Monday, 22 May 2023.
For further information please contact:
Integrated Diagnostic Holdings plc
+20(0)12 2255 7445
Nancy Fahmy
Investor Relations Director
Company Secretary: IDHLondon@linkgroup.co.uk
Link Company Matters Limited
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOAEALSLEEADEFA